American Express‘ affluent cardholders are showing few signs of curbing their spending, and younger customers drove growth in first-quarter transaction volumes, Chief Financial Officer Christophe Le Caillec told CNBC.
Billed business on AmEx cards rose 6% in the period, or 7% when adjusted for the impact of the leap year, the company reported Thursday, which shows that the bump in spending late last year continued into 2025, according to Le Caillec.
Those trends have continued into April, the CFO said, despite sharp declines in stocks this month amid concerns that President Donald Trump’s tariff policies will cause a recession.
The dynamic, which helped AmEx top expectations for first-quarter profit, shows that the company’s wealthier customer base may help to insulate it from concerns about tariffs and stubborn inflation. On the other end of the credit spectrum, Synchrony Financial, which offers store cards for dozens of popular retailers, has warned of a spending slowdown.
“There’s a lot of stability and strength, despite the news and the environment,” Le Caillec said.
Growth at AmEx came from younger cardholders, with millennial and Gen Z members spending 14% more in the quarter. Gen X and Baby Boomer cardholders showed more caution, registering 5% and 1% increases, respectively.
Le Caillec said it’s difficult to discern whether cardholders were pulling forward purchases because of the looming tariffs, creating an artificial boost to purchase volumes, as JPMorgan executives said last week. But some small businesses may be doing so to build inventory because of concerns about the duties increasing costs, he added.
Airline slump
One category in particular gave Le Caillec confidence that the spending trends may be durable.
“Restaurant spend is up 8%,” the CFO said. “This is the ultimate discretionary expense, it’s not something you can bring forward, and so it’s really a good indicator of the strength of our cardmember base and the confidence they have.”
If there was a weak area besides the spending slowdown from older Americans, it was in airline transactions, according to the company’s earnings presentation. The category grew just 3%, or 4% when adjusted for the leap year, after climbing 13% in the fourth quarter.
But while airlines, retailers and other corporations have pulled their earnings guidance on tariff uncertainty, AmEx was holding firm.
It maintained its guidance for revenue growth of 8% to 10% and earnings of $15 to $15.50 per share this year, Le Caillec said.
In the company’s presentation, though, it added a new caveat to its guidance: “Subject to the Macroeconomic Environment.”
Fox News and Newsmax television studios are seen in the Fiserv Forum on the day before the Republican National Convention begins, in Milwaukee, Wisconsin, July 14, 2024.
Joe Raedle | Getty Images News | Getty Images
Newsmax went public on the New York Stock Exchange on Monday, as the conservative cable news network audience has grown after the election of President Donald Trump and other right-wing politicians.
The network began trading under the symbol “NMAX” late Monday morning, opening at $14 a share after pricing at $10 a share. It soared more than 700% in volatile trading on Monday.
Newsmax’s stock closed at $83.51 for the day.
In September, Newsmax announced its plans for an initial public offering in early 2025. On Friday, the company said it raised $75 million through the sale of 7.5 million shares of Class B common stock at a price of $10 per share.
A pure-play TV network IPO in the U.S. is a rarity, with Dealogic data showing there hasn’t been one comparable to Newsmax in recent decades. Newsmax’s IPO comes at a time when traditional cable TV has suffered as consumers flee the bundle in favor of streaming. Now, news and live sports nab the biggest audiences and most advertising revenue dollars.
The debut also comes as the audience for right-wing prime-time content has grown with the rise of Trump and other right-leaning politicians in recent elections.
Christopher Ruddy, the company’s founder and CEO, said Monday on CNBC’s “Squawk Box” that he saw an opportunity to join the mix since Fox Corp.’s Fox News didn’t have a competitor in the “center right market.”
“I think there was a demand for more competition against Fox,” Ruddy said Monday. Ruddy founded Newsmax in 1998 as a digital offering before it became a cable TV network in 2014.
While the cable news landscape is dominated by Fox News, CNN and MSNBC, Newsmax has grown its audience in recent years and is offered through most major pay-TV providers.
Ruddy on Monday said that Newsmax is the “No. 4 cable news channel in the United States, right behind CNN.” Nielsen confirmed Monday that Newsmax ratings have “consistently” been in the fourth spot behind Fox News, MSNBC and CNN.
Still, Newsmax’s audience has yet to reach the breadth of Fox News, according to Nielsen data. Between Dec. 30 and March 20, Newsmax had an average of 309,000 primetime viewers and 211,000 daytime viewers. Fox News attracted an average of nearly 3.1 million primetime viewers and roughly 2 million daytime viewers during the same period.
Overall, Newsmax ranks in the top 20 among cable network average viewership in both prime time and daytime, Nielsen said Monday.
“I think it’s a pretty big achievement for a 10-year-old, new cable company,” Ruddy said Monday on “Squawk Box.”
As its popularity has risen, Newsmax has negotiated receiving licensing fees from cable TV providers. In its early days, Newsmax relied on advertising revenue. In 2023, it resolved a dispute with DirecTV — which led to it being dropped from the pay TV provider for a short period — after pushing to receive fees.
As the company went public, Ruddy downplayed the pro-Trump leanings of Newsmax — which reached a $40 million settlement last year with Smartmatic over the network’s false claims that the voting machine company helped to rig the 2020 presidential election in favor of former President Joe Biden.
“We believe we’re conservative with an independent news mission, and ask tough questions of the Trump administration,” Ruddy said Monday on “Squawk Box.”
In a post on social media platform X on Tuesday, Ruddy said he received a call from Trump and that the conversation touched on various topics, including the company’s upcoming IPO. “I shared with Potus my new saying: ‘A rising Trump lifts all boats!’” Ruddy wrote.
A recent move by the Trump administration to substantially lower funding from the National Institutes of Health for research institutions around the country has investors fearing meaningful losses for life science tools companies. The NIH announced in early February that it would cap research funding at 15% for “indirect costs” – those that aren’t directly tied to specific research projects, such as overhead and administrative costs. The new cap is below the average indirect cost rate of between 27% and 28% and well under the rates of more than 60% that universities such as Harvard, Yale and Johns Hopkins receive. The agency has estimated that the proposed indirect funding cuts would amount to more than $4 billion in savings per year for the federal government. That’s relative to the institutes’ total budget for fiscal 2024 of more than $47 billion , which makes the NIH the world’s largest single public funder of biomedical and behavioral research. However, the steep cuts from the Trump administration are already being challenged in court. Earlier this month, a federal judge blocked the White House from carrying out the reductions. Some lawmakers have spoken out against the cuts, including Republicans such as Sen. Susan Collins of Maine – who said in a statement last month that it was “poorly conceived.” As uncertainty hangs over the future of NIH-funded research, some on Wall Street are raising the alarm over stocks that could take a hit. “Approximately 60% of U.S. academic research is funded by federal government agencies, and the NIH is the single largest source of A & G (Academic & Government) revenues for Tools companies,” Bank of America analyst Michael Ryskin wrote in a Feb. 25 note. “Regardless how it’s resolved in the end, capping all indirect costs at 15% could significantly impact the ability of those institutions to provide the facilities and support for certain types of research, as individual scientists / grants are not going to be capable of supporting entire vivariums or complex infrastructure,” the analyst continued. ‘Bracing for weakness’ In the aftermath of the NIH announcement, shares of many notable life science tools companies have lagged the broader market. While the S & P 500 has fallen 4% in the past month, Bruker slid more than 14%, and Illumina has dropped about 10.8%. Agilent and 10x Genomics declined more than 11% and 19%, respectively. Thermo Fisher Scientific has shed more than 3% in that time. Among those names, 10x Genomics, Illumina and Bruker have the highest A & G exposure in BofA’s coverage. While direct NIH exposure is “more limited,” that could still be meaningful if funding is frozen, Ryskin wrote. That comes as the life science tools space was already coming under pressure over the past couple years. William Blair’s Matt Larew told CNBC that this is largely because the space was coming off the Covid-19 pandemic, when clients made significant purchases in areas like equipment and consumables, overstocking many products because of supply chain concerns. “Due to the weak macro in the last couple of years, growth in this space was really challenged, because customers had a lot of the product already,” the analyst said. “Finally, you’d gotten through that, and so the space for the first two weeks of the year actually outperformed the market for maybe the first time in a couple of years.” Those gains have now just completely disappeared, he pointed out. ILMN TXG,TMO,BRKR 5Y mountain ILMN, TGX, TMO and BRKR in past 5 years “From an investor standpoint, I think people are very frustrated with what historically is viewed as a durable, noncyclical part of the market acting … more sensitive to these changing net market conditions,” he continued. “It’s certainly a problem for the stocks. No question.” Larew also said that the current quarter and probably the next quarter are “unquestionably” going to look challenging for companies. Other analysts hold a similar view. “People are bracing for weakness,” TD Cowen analyst Daniel Brennan said in an interview with CNBC, adding that the market is preparing for impact particularly on companies’ first-quarter earnings results over the next couple of months. “People are trying to figure out: Is it priced in?” Nevertheless, Brennan noted that any pressure on the stocks might offer a silver lining for those on the Street. “If there is weakness, maybe it creates an opportunity for investors to step in,” he continued. Longer-term turmoil? If the indirect costs cap is passed, institutions could collectively stand to lose billions of dollars in their research budgets. According to estimates from a calculator designed by Data for the Common Good at the University of Chicago, the total research budget loss would be more than $6.9 billion, based on fiscal 2024 figures. The D4CG also notes that the calculator is likely underestimating the amount of lost indirect costs, meaning the loss may actually be even greater. Tara LeGates, who has been a researcher in biological sciences at the University of Maryland, Baltimore County, since 2019, emphasized this will have a massive impact on the research projects she proposes. On top of that, she said the local economy is going to suffer as university staff could be laid off because those institutions won’t have the means to support them. “The indirects essentially are providing the infrastructure where I can do the project,” she told CNBC. “I can have a building with the lights on and electricity, and the students and the staff there to be able to actually accomplish those research goals. That evaporates.” Moving forward, LeGates believes that universities aren’t going to have a reason to support research anymore with this policy change, anticipating that more hiring and admissions freezes for staff and students could ensue. Just a month ago, Stanford University, for instance, announced a staff hiring freeze , citing uncertainty around NIH cuts. “We’re going to see a huge stalling of scientific progress, because if universities are closing buildings because they can’t operate them or they have fewer people to actually do the work, things just aren’t going to get done,” LeGates added. On that front, analyst Puneet Souda at Leerink said that the long-term impact of these cuts would threaten the U.S.’ global position in scientific research, especially when it comes to drug discovery. “We’re talking fundamental, novel innovation, and that’s what the American biomedical research system is able to do,” he said to CNBC. “It doesn’t happen like this anywhere in the world, and that’s what’s at risk if these cuts are implemented.”
Reliance Industries maintained its position as the top company in the Sensex rankings, followed closely by Tata Consultancy Services (TCS).
Sensex rose by 657 points, Nifty up by 226 points.
The past week has been nothing short of remarkable for the stock market, with the benchmark index of the Bombay Stock Exchange (BSE Sensex) rising by a robust 657.48 points, or 0.84%. Meanwhile, the National Stock Exchange’s Nifty index surged by 225.9 points, or 0.95%. A total of Rs 86,847.88 crore was added to the combined market value of the top six companies on the Sensex during this period, with HDFC Bank and Reliance Industries leading the charge and rewarding their investors handsomely.
Market Performance of Key Companies
Over the course of the week, the market capitalisation of several major companies saw significant gains, while a few others experienced declines. Notably, HDFC Bank, Reliance Industries, ICICI Bank, Bharti Airtel, ITC, and Hindustan Unilever emerged as the big winners, posting impressive increases in their market valuations.
On the other hand, stocks like Tata Consultancy Services (TCS), Infosys, State Bank of India (SBI), and Life Insurance Corporation of India (LIC) witnessed a dip in their market value.
Companies That Benefitted the Most
According to PTI, HDFC Bank saw its market capitalisation jump by Rs 20,235.95 crore, reaching Rs 13,74,945.30 crore. Similarly, Reliance Industries experienced a rise of Rs 20,230.9 crore, with its market value standing at Rs 16,52,235.07 crore. ITC also saw a substantial increase of Rs 17,933.49 crore, bringing its market capitalisation to Rs 5,99,185.81 crore.
ICICI Bank gained Rs 15,254.01 crore, pushing its market value to Rs 9,22,703.05 crore. Bharti Airtel added Rs 11,948.24 crore to its market valuation, which rose to Rs 9,10,735.22 crore. Finally, Hindustan Unilever recorded an increase of Rs 1,245.29 crore, with its market capitalisation reaching Rs 5,49,863.10 crore.
In contrast, several companies faced a decline in their market capitalisation during the week. State Bank of India (SBI) saw its market value drop by Rs 11,557.39 crore, reaching Rs 7,13,567.99 crore. LIC’s market capitalisation fell by Rs 8,412.24 crore, bringing its valuation to Rs 5,61,406.80 crore. Infosys recorded a decline of Rs 2,283.75 crore, with its market value standing at Rs 7,95,803.15 crore. Finally, Tata Consultancy Services (TCS) saw a marginal decrease of Rs 36.18 crore, bringing its valuation to Rs 15,08,000.79 crore.
The Top 10 Companies of the Sensex
At the end of the week, Reliance Industries maintained its position as the top company in the Sensex rankings, followed closely by Tata Consultancy Services (TCS), HDFC Bank, ICICI Bank, Bharti Airtel, Infosys, State Bank of India, ITC, LIC, and Hindustan Unilever.
Newsbusiness Sensex Rises By Rs 87,000 Crore In 5 Days; HDFC Bank, Reliance Industries Lead Market Surge
President-elect Donald Trump at a viewing of a test-flight launch of the SpaceX Starship rocket in Brownsville, Texas, Nov. 19, 2024.
Brandon Bell | Getty Images News | Getty Images
As Inauguration Day nears, investors are trying to unravel what booms or busts lay ahead under President-elect Donald Trump.
Trump’s campaign promises — from tariffs to mass deportations, tax cuts and deregulation — and his picks to lead federal agencies suggest both risks and rewards for various investment sectors, according to market experts.
Republican control of both chambers of Congress may grant Trump greater leeway to enact his pledges, experts said. However, their scope and timing is far from clear.
More from FA Playbook:
Here’s a look at other stories impacting the financial advisor business.
“There’s so much uncertainty right now,” said Jeremy Goldberg, a certified financial planner, portfolio manager and research analyst at Professional Advisory Services, which ranked No. 37 on CNBC’s annual Financial Advisor 100 list.
“I wouldn’t be making large bets one way or another,” Goldberg said.
Sectors often fare differently than expected
Past market results show why it’s difficult to predict the sectors that may win or lose under a new president, according to Larry Adam, chief investment officer at Raymond James.
When Trump was elected in 2016, financials, industrials and energy outperformed the S&P 500 in the first week. However, for the remaining three years and 51 weeks, those same sectors significantly underperformed, Adam said.
“The market is known to have these knee-jerk reactions trying to anticipate where things go very quickly, but they don’t necessarily last,” Adam said.
What’s more, sectors that are expected to do well or badly based on a president’s policies have sometimes gone the opposite way, according to Adam.
For example, the energy sector was down by 8.4% during Trump’s first administration, despite deregulation, record oil production and a rise in oil prices. Yet the energy sector climbed 22.9% under Biden as of Nov. 19, despite the administration’s push for renewables and sustainability.
For that reason, Raymond James ranks politics eighth for its potential impact on sectors. The seven factors that have more influence, according to the firm, are economic growth, fundamentals, monetary policy, interest rates and inflation, valuations, sentiment and corporate activity.
Here’s how Trump’s policy stances could influence eight sectors: autos, banks, building materials and construction, cryptocurrency, energy, health care, retail and technology.
Automobiles
Monty Rakusen | Digitalvision | Getty Images
The auto sector — like many others — will likely be a mixed bag, experts said.
Trump’s antipathy for electric vehicles is likely to create headwinds for EV producers.
His administration may try to roll back regulations such as a Biden-era tailpipe-emissions rule expected to push broader adoption of EVs and hybrids. He also intends to kill consumer EV tax credits worth up to $7,500 — although states such as California may try to enact their own EV rebates, blunting the impact.
Losing the federal credit would make EVs more costly, driving down sales and perhaps making “per unit economics even less favorable” for automakers, John Murphy, a research analyst at Bank of America Securities, wrote in a Nov. 21 research note.
Some companies seem well-positioned, though: Ford Motor, for example, “has a healthy pipeline of hybrid vehicles as well as traditional [internal combustion engine] vehicles to supplement the EV offerings,” Murphy wrote.
Tariffs and trade conflict pose threats to the auto industry, since the U.S. relies heavily on other nations to manufacture cars and parts, said Callie Cox, chief market strategist at Ritholtz Wealth Management.
They “could affect the cost and availability of cars we see in the U.S. market,” Cox said.
In that case, the Federal Reserve may have to keep interest rates higher for longer than anticipated. Higher borrowing costs may weigh on consumers’ desire or ability to buy cars, Cox said.
However, lower EV production could be a boon for companies that manufacture traditional gasoline cars, experts said.
Trump has also called for a “drill, baby, drill” approach to oil production. Greater supply could reduce gas prices, supporting demand for gas vehicles, experts said. But trade wars and sanctions on Iran and Venezuela could have the opposite impact, too.
— Greg Iacurci
Banks
President Donald Trump stands next to JPMorgan Chase CEO Jamie Dimon, left, in the State Dining Room of the White House in Washington, Feb. 3, 2017.
Andrew Harrer | Bloomberg | Getty Images
Trump’s first administration eased certain regulations for banking rules, fintech firms and financial startups.
Likewise, Trump’s second term is expected to usher in lighter financial regulations.
That may help bolster profitability in the sector, and therefore stock prices, said Brian Spinelli, co-chief investment officer at Halbert Hargrove in Long Beach, California, which is No. 54 on the 2024 CNBC FA 100 list.
“The larger banks probably benefit more from that,” Spinelli said.
Less regulation — combined with the prospect that interest rates could stay higher — will provide a net positive for the bank industry, since banks may be able to lend out more risk-based capital, said David Rea, president of Salem Investment Counselors in Winston-Salem, North Carolina, which is No. 8 on the 2024 CNBC FA 100 list.
One issue that emerged this year that could resurface is concern about regional banks’ exposure to commercial real estate, Spinelli said.
“It wasn’t that long ago, and I don’t think those problems disappeared,” Spinelli said. “So you question, is that still looming out there?”
— Lorie Konish
Building materials and construction
Bill Varie | The Image Bank | Getty Images
The housing market has been “frozen” in recent years by high mortgage rates, said Cox, of Ritholtz.
Lower rates would likely be a “catalyst” for housing and associated companies, she said.
However, that may not materialize — quickly, at least — under Trump, she said. If policies such as tariffs, tax cuts and mass deportations stoke inflation, the Federal Reserve may have to keep interest rates higher for longer than anticipated, which would likely prop up mortgage rates and weigh on housing and related sectors, she said.
The whims of the housing market affect retailers, too: Home goods stores may not fare well if people aren’t buying, renovating and decorating new homes, Cox said.
That said, deregulation could be “absolutely huge” for the sector if it accelerates building timelines and reduces costs for developers, Goldberg said.
Trump has called for opening public land to builders and creating tax incentives for homebuyers, without providing much detail.
Housing policy will be “one of the most-watched initiatives coming out of the next administration,” Cox said. “We haven’t gotten a lot of clarity on that front.”
“If we see realistic and well-thought-out policies, you could see real estate stocks and related stocks” such as real estate investment trusts, home improvement retailers and home builders respond well, Cox said.
— Greg Iacurci
Crypto
Republican presidential nominee and former U.S. President Donald Trump gestures at the Bitcoin 2024 event in Nashville, Tennessee, U.S., July 27, 2024.
Kevin Wurm | Reuters
Trump’s election has brought a new bullishness to cryptocurrencies, with bitcoin nearing a new $100,000 benchmark before its recent runup ended.
As president, Trump is expected to embrace crypto more than any of his predecessors.
Notably, he has already launched a crypto platform, World Liberty Financial, that will encourage the use of digital coins.
Those developments come as new ways of investing in crypto have emerged this year, with the January launch of spot bitcoin ETFs, and more recently, the addition of bitcoin ETF options.
Yet financial advisors are hesitant, with only about 2.6% recommending crypto to their clients, an April survey from Cerulli Associates found. Roughly 12.1% said they would be willing to use it or discuss it based on the client’s preference. Still, 58.9% of advisors said they do not expect to ever use cryptocurrency with clients.
“The No. 1 reason why advisors aren’t investing in cryptocurrency on behalf of their clients is they don’t believe it’s suitable for client portfolios,” said Matt Apkarian,associate director in Cerulli’s product development practice.
Even for advisors who do expect they may use crypto at some point, it’s “wait and see,” particularly regarding how the regulatory environment plays out, Apkarian said.
However, investors are showing interest in cryptocurrency, with 90% of advisors receiving questions on the subject, according to research from Christina Lynn, a certified financial planner and practice management consultant at Mariner Wealth Advisors.
For those investors, exchange-traded funds are a good starting place, Lynn said, since there’s less chance of falling victim to one of crypto’s pitfalls such as scams or losing the keys, the unique alphanumeric codes attached to the investments. Because crypto can be more volatile, it’s best not to invest any money you expect you’ll need to pay for near-term goals, she said.
Investors would also be wise to think of cryptocurrency like an alternative investment and limit the allocation to 1% to 5% of their overall portfolio, Lynn said.
“You don’t need to have a lot of this to have it go a long way,” Lynn said.
— Lorie Konish
Energy
President Donald Trump gestures after delivering a speech at a Double Eagle Energy Holdings LLC oil rig in Midland, Texas, July 29, 2020.
Cooper Neill | Bloomberg | Getty Images
As of Nov. 19, energy has been the top-performing sector under President Joe Biden, with a 22.9% gain, even with the administration’s push for renewables and sustainability, according to Raymond James.
Yet it remains to be seen whether that performance can continue under Trump, who has advocated for more oil, gas and coal production. The outlook for the sector could change if Trump acts on a campaign threat to repeal the Inflation Reduction Act, a law enacted under Biden that includes clean energy incentives.
If Trump continues to make it easier to create more oil supply, that might not be a great thing for oil companies, according to Adam, of Raymond James.
“Because there’s more supply, it may tamp down on the price of oil, and that’s one of the biggest drivers of that sector,” Adam said.
Eagle Global Advisors, a Houston-based investment management firm that specializes in energy infrastructure, is “cautiously optimistic” about Trump’s impact on the sector, according to portfolio manager Mike Cerasoli. Eagle Global Advisors is No. 35 on the 2024 CNBC FA 100 list.
“We would say we’re probably more on the optimistic side than the cautious side,” Cerasoli said. “But if we know anything about Trump it’s that he’s a wild card.”
A lot of the Inflation Reduction Act may stay intact, since the top states that benefited financially from the law also handed Trump a victory in the election, according to Cerasoli.
When Biden won in 2020, there was a lot of panic about the outlook for energy, oil and gas. Cerasoli recalls writing in a third-quarter letter that year, “I don’t think it’s going to be as bad as you think.”
Four years later, he has the same message for investors on the outlook for renewables. In the days following Trump’s inauguration, Cerasoli expects there may be a deluge of executive orders.
“Once you get past that, you’ll get a sense of exactly how he’s going to treat energy,” Cerasoli said. “I think people will realize that it’s not the end of the world for renewables.”
— Lorie Konish
Health care
Medicine vials on a production line.
Comezora | Moment | Getty Images
Trump nominated Robert F. Kennedy Jr. as head of the Department of Health and Human Services.
RFK would be a “huge wild card” for the health-care sector if the U.S. Senate were to confirm him, said Goldberg, of Professional Advisory Services.
RFK is a prominent vaccine skeptic, which may bode ill for big vaccine makers such as Merck, Pfizer and Moderna, said David Weinstein, a portfolio manager and senior vice president at Dana Investment Advisors, No. 4 on CNBC’s annual FA 100 ranking.
Cuts to Medicaid and the Affordable Care Act, also known as Obamacare, are also likely on the table to reduce government spending and raise money for a tax-cut package, experts said.
Publicly traded health companies such as Centene, HCA Healthcare and UnitedHealth might be affected by lower volumes of Medicaid patients or consumers who face higher health-care premiums after losing ACA subsidies, for example, Weinstein said.
Robert F. Kennedy Jr. during the UFC 309 event at Madison Square Garden in New York City, Nov. 16, 2024.
Chris Unger | Ufc | Getty Images
Medical tech providers — especially those that supply electronics with semiconductors sourced from China — could be burdened by tariffs, he added.
Conversely, deregulation might help certain pharmaceutical companies such as Thermo Fisher Scientific and Charles River Laboratories, which may benefit from faster approvals from the Food and Drug Administration, Goldberg said.
Vivek Ramaswamy, a former biotech executive whom Trump appointed as co-head of a new advisory panel called the “Department of Government Efficiency,” has called for streamlined drug approvals. But Kennedy has advocated for more oversight.
“There’s a real dichotomy here,” Weinstein said.
“Where do we end up? Maybe where we are right now,” he added.
— Greg Iacurci
Retail
Thomas Barwick | Digitalvision | Getty Images
Tax cuts may boost consumers’ discretionary income, which would be a boon for companies selling consumer electronics, clothes, luxury goods and other items, Goldberg said.
Then again, there’s a “high probability” of tariffs, Weinstein said.
Retailers would likely pass on at least some of that additional cost to consumers, experts said.
All physical goods, from apparel to footwear, tools and appliances are at risk from tariffs, Weinstein said. Tariff impact would depend on how the policies are structured.
Home Depot, Lowe’s and Walmart, for example, source a relatively big chunk of their goods from abroad, Weinstein said.
Home Depot CEO and President Ted Decker said Nov. 12 during the firm’s third-quarter earnings call that the company sources more than half its goods from the U.S. and North America, but “there certainly will be an impact.”
“Whatever happens in tariffs will be an industrywide impact,” Decker said. “It won’t discriminate against different retailers and distributors who are importing goods.”
It’s a good idea for investors to own “high quality” retailers without a lot of debt and with diversified inventory sources, Goldberg said. He cited TJX Companies, which owns stores including TJ Maxx, Marshalls and HomeGoods, as an example.
“Direct imports are a small portion of [its] business and TJX sources from a variety of countries outside of China,” Lorraine Hutchinson, a Bank of America Securities research analyst, wrote in a Nov. 21 note.
Deregulation may be positive for smaller retailers and franchises, which tend to be more sensitive to labor laws and environmental and compliance costs, Goldberg said.
— Greg Iacurci
Technology
Former President Donald J. Trump speaks about filing class-action lawsuits targeting Facebook, Google and Twitter and their CEOs, escalating his long-running battle with the companies following their suspensions of his social media accounts, during a press conference at the Trump National Golf Club in Bedminster, New Jersey, July 07, 2021.
Jabin Botsford | The Washington Post | Getty Images
Even broadly diversified investors may find it difficult to escape those names, as they are among the top weighted companies in the S&P 500 index.
Information technology — which includes all those stocks except Amazon and Google parent Alphabet — comprises the largest sector in the S&P 500 index, with more than 31%.
Trump is poised to have an influence on looming antitrust issues, amid considerations as to whether Google’s influence on online search should be limited.
Any tariffs put in place may also prompt some sales to decline or the cost of raw materials to go up, said Rea of Salem Investment Counselors.
Nevertheless, Rea said his firm continues to have a “pretty heavy” tech allocation, with strong expectations for generative artificial intelligence. However, the firm does not own Tesla, due to its expensive valuation, and has recently been selling software company Palantir, a winning stock that may have gotten ahead of itself, he said.
Technology valuations are trading well into the high double digits on a price-to-earnings basis, which often signals forward returns will decline, according to Halbert Hargrove’s Spinelli.
Consequently, prospective investors who come in now would basically be buying high, he said.
“If you think you’re going to get the same double-digit returns in the next five years, sure, it could happen on a one-year basis,” Spinelli said. “But your chances historically have been that your returns come down.”
Robert F. Kennedy Jr. attends a campaign event for Republican presidential nominee and former U.S. President Donald Trump in Milwaukee, Wisconsin, U.S. November 1, 2024.
Joel Angel Juarez | Reuters
Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect Donald Trump’s pick for Health and Human Services secretary, could recommend removing fluoride from the U.S. water system, a move that would lead to a boom in dental visits.
Shares of Henry Schein shares jumped about 7.5%, notching its best day since 2022. Fellow dental product makers Dentsply Sirona and Envista also rose in the session.
Monday’s moves come as investors ready for public health changes under a second Trump administration. Kennedy posted on X before the presidential election this month that a “Trump White House will advise all U.S. water systems to remove fluoride from public water.”
1-day chart
Fluoride has long been shown as an effective method for fighting cavities. But the mineral has found itself at the center of a nationwide fight that’s led some local communities to end programs centered on its insertion into public water.
While Kennedy will need to win Senate approval to take the job, market participants are already zeroing in on a group of stocks that make dental hygiene products as potential beneficiaries of his policies. That’s because taking fluoride out of water would actually put the tooth cleaning industry in higher demand as consumers look elsewhere to fight cavities, according to firm Gordon Haskett.
A general view of the Henry Schein Inc. building a distributor of health care products and services with a presence in 32 countries, as photographed in Melville, New York.
Bruce Bennett | Getty Images
“The thought here is RFK will bring to HHS a voice that is in favor of reducing, or eliminating, the amount of fluoridation that is added to drinking water,” Don Bilson, Gordon Haskett’s head of event-driven research, told clients in a Monday note. “This will, in turn, lead to an acceleration of tooth decay and more dental visits.”
Henry Schein shares took a leg up in afternoon trading following a Reuters report that activist investor Ananym Capital was calling for changes at the company. The newly launched firm, which is led by Charlie Penner and Alex Silver, believes the board should be shaken up and costs should be cut, among other ideas.
Henry Schein and other stocks in the space offer a bright spot within a sector that has largely struggled since the election. The Health Care Select Sector SPDR Fund (XLV) has tumbled more than 3% in November, putting it on track for its first three-month losing steak since last year. By comparison, the broad S&P 500 has climbed more than 3% in the month.
Gordon Haskett’s Bilson also pointed out that dental stocks were some of the few “spared” health-focused equities as investors responded to the announcement of Kennedy’s nomination last week. Pharmaceutical names were under pressure given Kennedy’s reputation as a vaccine skeptic, while processed food stocks took a hit as traders geared up for increased scrutiny of so-called junk food.
“It caused widespread selling across the healthcare landscape,” Bilson said of the decision to select Kennedy. “Drugmakers, contract research organizations, and health insurers all felt the quake. Rather than stop there, the damage spilled into packaged foods. And advertising.”
While the market appears to be moving on Kennedy’s nomination, Bilson said that regulatory changes would likely take years to come into effect. He also noted that drinking water should fall more under the Environmental Protection Agency than Health and Human Services.
Lucid Motors CEO Peter Rawlinson poses at the Nasdaq MarketSite as Lucid Motors (Nasdaq: LCID) begins trading on the Nasdaq stock exchange after completing its business combination with Churchill Capital Corp IV in New York City, New York, July 26, 2021.
Andrew Kelly | Reuters
DETROIT — Investors misinterpreted a public offering on Wednesday by Lucid Group that raised roughly $1.75 billion — and led to the stock’s worst daily performance in nearly three years, CEO Peter Rawlinson told CNBC.
Rawlinson said the raise, which included a public offering of nearly 262.5 million shares of its common stock, was a timely, strategic business decision to ensure the electric vehicle company has enough capital for its ongoing operations and growth plans. It also should alleviate any potential worries that the company would need to issue a “going concern” disclosure regarding its operations, he said.
“We’d signaled that we had a cash runway to Q4 next year. As a Nasdaq company, we have to avoid a going concern. And a going concern is issued within 12 months of your financial runway,” Rawlinson said Monday from the company’s newly opened offices in suburban Detroit. “So, it should have been no surprise to anybody.”
But Wall Street analysts largely took a negative view of the move due to its timing. Several said the raise was unnecessary or came earlier than expected for the company, which had $5.16 billion of total liquidity to end the third quarter. That included more than $4 billion in cash, cash equivalents and investment balances.
The announced transactions also come two months after Lucid said Saudi Arabia’s Public Investment Fund had agreed to supply the company with $1.5 billion in cash, as the EV maker looks to add new models to its product line.
“A cap raise was slightly larger and earlier than we had expected,” Morgan Stanley analyst Adam Jonas wrote following the raise being announced Wednesday after markets closed.
Lucid’s stock
RBC Capital Markets analyst Tom Narayan shared similar thoughts: “We suspect that investors will wonder why LCID is raising more capital just after it secured the PIF capital in August, and at currently depressed share price levels. We expect Lucid shares to trade sharply lower as a result,” he wrote in an investor note Wednesday night.
Rawlinson on Monday reiterated that the company would raise capital “opportunistically.” He said the company’s current funds now secure its capital into 2026, ahead of it launching a new midsize platform later that year.
“This is exactly as expected. It is exactly to the playbook. It should have come as zero surprise to anyone,” he said. “And why did I choose this moment? Because I didn’t want to string it out to the end, because I didn’t have to.”
Shares of Lucid declined about 18% on Thursday after the announcement — marking the worst daily decline for the company since December 2021.
Rawlinson said Lucid is currently in a highly capital-intensive investment period as it expands its sole U.S. factory in Arizona; builds a second plant in Saudi Arabia; prepares to launch its second product, an SUV called Gravity; develops its next-generation powertrain; and builds out its retail and service network.
“Those five categories are the long-term investment for the future that we’re making now,” Rawlinson said. “Have we got to cut costs with every car we’re making? Absolutely.”
Wednesday’s announcement was made in conjunction with plans for Lucid’s majority stockholder and affiliate of PIF, Ayar Third Investment Co., to purchase more than 374.7 million shares of common stock from Lucid to maintain its roughly 59% ownership of the company.
Such a transaction is called pro rata, which allows an investor such as PIF to participate in future rounds of financing and retain its ownership stake. It’s something the PIF has routinely done with Lucid.
Individual investors were likely concerned by share dilution following the action, but Rawlinson said the continued support of the PIF should be viewed as a positive.
“I think it’s been misinterpreted and misreported,” Rawlinson said. “The norm is to go pro rata. If we didn’t go pro rata, it surely would be a signal that the PIF were losing faith in us.”
Lucid last week said the public offering was expected to raise about $1.67 billion, with a 30-day option for underwriter BofA Securities to purchase up to nearly 39.37 million additional shares of Lucid’s common stock as well.
Lucid has reported record deliveries in 2024 of its current model, an all-electric sedan called Air. The company expects to produce 9,000 vehicles this year. Production of its Gravity SUV is expected to start by the end of this year.
This year’s presidential election is already sending health-care stocks on a wild ride. Historically, shifts in political control have created “increased volatility” across the sector, sending investors “to look for areas of safety,” Raymond James analyst Chris Meekins said in a July 7 note. “This election is likely to produce distinct, binary, opposing health policy outcomes depending on who wins.” With subsidies for the Affordable Care Act expiring next year and intense scrutiny of Medicare Advantage plans in recent months, health insurers may be even more sensitive to this pattern than usual. Indeed, it already appears evident in how managed-care stocks are trading. At the start of the week, traders seemed to have come to the conclusion that former U.S. President Donald Trump was amassing an unbeatable lead against Joe Biden . The current president’s reelection campaign has been struggling since Biden’s disastrous debate performance on June 27. Calls for him to bow out of the race quieted briefly after a failed assassination attempt against Trump, but on Thursday pressure was building once again. A look at how UnitedHealth Group shares have traded amid these headlines gives a sense of the swings in sentiment. As of Thursday’s close, the stock had been underperforming the market with a 7% gain year to date. However, since the presidential debate, the shares are up nearly 17%. The stock hit a fresh 52-week high in trading Wednesday, but has moved off its high in recent sessions as it started to look as though Biden might step aside . UNH 1M mountain UnitedHealth stock over the past month. The broader health-care sector, a defensive, “late-cycle” group, generally struggles in election years and the year after — and historically outperforms the second year after an election, Meekins noted. Most health-care sectors also perform “much better” when a Republican wins the presidency. The broad universe of health-care stocks has underperformed by roughly 19% during the Biden presidency, the analyst said. What a GOP victory means Analysts expect Republican leadership would lessen regulatory scrutiny by the Federal Trade Commission and Department of Justice, while still tamp down drug prices. However, it could mean the end of expanded individual health-care subsidies. That’s important because this benefit, which was established under the ACA, or Obamacare, reduces the monthly premiums and out-of-pocket costs for middle- and low-income individuals. It is set to expire at the end of 2025, and a GOP sweep could assure that. Raymond James’ Meekins said the end of subsidies could lead to a large number of newly uninsured people, hurting hospitals and managed-care companies, which would see lower enrollment. On the flip side, analysts see a Trump win as a positive for Medicare Advantage carriers. Think Centene , Molina Healthcare , UnitedHealth and Humana , among others. Medicare Advantage is a kind of Medicare health plan offered by private insurance companies that, through annual contracts, generally provide the same coverage as original Medicare, but often with additional benefits such as vision and dental coverage. “A Trump administration would be more favorable from a rate perspective, which will help alleviate some of the cost issues [Medicare Advantage carriers] have been feeling and the pressure they’ve been feeling on the medical costs side, compared to what they’ve experienced under the Biden administration so far,” Meekins said. History bodes well for the group. Managed-care companies historically buck the broader trend of health stocks and outperform in the first year after an election, according to Raymond James. Analysts from several firms, including Raymond James, Bernstein and RBC Capital Markets, believe UnitedHealth, Humana and CVS Health would be among the biggest beneficiaries of a Trump win. Recent gains at UnitedHealth, the largest private insurer in the U.S., not only reflect the shifting political winds. There has been a turnaround in investor enthusiasm due to a strong second quarter that reignited confidence in the company’s outlook. Jefferies analyst David Windley praised the company’s efforts to pinch costs, saying it could lead to a “superior ’25 setup” for the stock. Windley sees a Trump win resulting in membership growth, and UnitedHealth appears “best positioned to capture the full economic opportunity.” He holds a buy rating and $647 price target on the stock, which implies the shares could jump nearly 15% from Thursday’s close. RBC Capital Markets analyst Ben Hendrix said UnitedHealth would see the most immediate upside among the managed-care organizations under a Trump administration as its Optum unit would benefit from an easing regulatory environment. Optum has helped fuel the company’s record profits by offering a range of primary-care, specialty and urgent-care services to nearly 104 million consumers . In late February, the DOJ launched an antitrust investigation to look into the role giant conglomerates have played in rising health-care costs. Alongside UnitedHealth and Humana, Raymond James analyst John Ransom also expects managed-care provider Alignment Healthcare to benefit from a GOP sweep, as he said these three names have relatively high exposure to Republican-favored Medicare Advantage plans and less or none to the ACA. Humana has lost more than 15% this year, but like UnitedHealth, its shares have risen nearly 8% since the presidential debate. Piper Sandler initiated coverage of Humana with an overweight rating and $392 price target on June 25, saying a “turnaround” for the company is underway, aided by a new CEO and the expected growth in the Medicare Advantage market. “We think the HUM brand has an enduring competitive moat … and we believe the company’s purpose-built healthcare delivery and services infrastructure should improve outcomes and bend the cost curve through center-based, at-home and pharmacy care over time,” the firm said, adding that the stock is cheaper than it appears. Telehealth and prescription drug provider GoodRx Holdings could also get a lift if a Republican sweep eliminates the ACA-enhanced subsidies, Ransom said. Shares are up more than 20 % year to date. “With the potential for millions of ACA members to lose insurance coverage, we believe GDRX could stand to benefit as individuals would increasingly seek prescription savings,” he said. What a Democratic victory means If Democrats overcome their recent struggles, either with Biden or another candidate, analysts see managed-care names linked to the ACA and hospitals as winners. In this scenario, Bernstein analyst Lance Wilkes expects Centene to benefit as the largest Medicaid managed-care organization. He has an outperform rating and bullish $94 price target on the stock, suggesting more than 43% potential upside. “We would see some stock price headwinds for CNC, but more limited due to valuation levels and lower focus on Medicaid reform this time,” he said. Centene shares are down more than 11% year to date. Unlike UnitedHealth, shares have fallen — down 3% — since the June debate. Raymond James sees Oscar Health , HCA Healthcare and Tenet Healthcare as beneficiaries of a victory by the left. “A Democratic sweep would almost guarantee an extension of the Affordable Care Act expanded subsidies, which would be a clear positive for OSCR,” Ransom said. About 95% of its membership comes from the ACA exchanges. Shares of Oscar Health are up a whopping 64% this year, but the stock has fallen 17% since the debate aired. It would also benefit HCA and Tenet Healthcare, given the pair’s exposure to Florida and Texas, he said. The two markets comprise roughly 36% of total ACA enrollment. When Raymond James initiated Oscar in late March with an outperform rating and $20 price target — now 33% higher than the stock’s latest close — Ransom acknowledged its fortunes would be sensitive to news around ACA subsidies. However, he expects Oscar’s new chief executive, the former head of CVS Health -owned Aetna, to boost earnings growth through cost cutting.
Saks Fifth Avenue parent HBC said on Thursday it will acquire Neiman Marcus Group in a $2.65 billion deal combining the storied retailers.
The combination will establish Saks Global, which will include Saks Fifth Avenue, Saks OFF 5TH, Neiman Marcus’ namesake department store chain and Bergdorf Goodman.
“We’re thrilled to take this step in bringing together these iconic luxury names,” HBC CEO Richard Baker. said in a statement. “For years, many in the industry have anticipated this transaction and the benefits it would drive for customers, partners and employees.”
“This is an exciting time in luxury retail,” Baker added, citing technological advancements that can “redefine” the customer experience. He was one of several executives between the two companies pointing to technology as a point of focus going forward.
As part of the deal, Saks.com CEO Marc Metrick will take the chief executive role for the Saks Global business. Ian Putnam, president and CEO of HBC Properties and Investments, will become CEO of Saks Global’s property and investments business. Both will report to Baker, who will serve as executive chairman at Saks Global.
Neiman Marcus Group CEO Geoffroy van Raemdonck called the partnership a “proactive choice in an evolving retail landscape.”
The deal comes amid what’s been a turbulent period for traditional brick-and-mortar retail in the wake of the ecommerce boom. That strain was exacerbated by post-pandemic demand for experiences, which pushed consumers to shell out for restaurants or travel instead of goods they stocked up on during lockdown.
The department store segment in particular has struggled to attract younger shoppers amid a broader pullback in discretionary spending.
Patrick Bertoletti, Geoffrey Esper and other contestants compete in the 2024 Nathan’s Famous Fourth of July International Hot Dog Eating Contest at Coney Island in New York City, U.S., July 4, 2024.
Jeenah Moon | Reuters
There’s a new top dog in the frankfurter eating world.
Patrick Bertoletti won Nathan’s Hot Dog Eating Contest, the annual competition held on July 4, marking the end of an era after 16-time winner Joey Chestnut’s falling out with the event’s organizer, Major League Eating.
Bertoletti, 39, from Illinois, consumed 58 hot dogs in this year’s 10-minute event, earning him the Mustard Yellow Belt in the men’s category. Miki Sudo set a new record in the women’s division with 51 wieners downed. After the beef between Chestnut and MLE, the contest was considered much more wide open than in the past several years.
MLE announced last month that it was parting ways with Chestnut, citing a rule that participants cannot strike endorsement deals with rivals of hot dog maker Nathan’s. MLE alleged at the time that Chestnut had partnered with a plant-based meat alternative company. Chestnut, also known as “Jaws,” has recently begun posting images on Instagram that feature Impossible Foods.
“For nearly two decades we have worked under the same basic hot dog exclusivity provisions,” the MLE said in a statement in June. “However, it seems that Joey and his managers have prioritized a new partnership with a different hot dog brand over our long-time relationship.”
Miki Sudo reacts as she wins women’s division of the 2024 Nathan’s Famous Fourth of July International Hot Dog Eating Contest at Coney Island in New York City, U.S., July 4, 2024.
Jeenah Moon | Reuters
Chestnut responded in a statement at the time that he was “gutted to learn from the media” of his banishment after 19 years. The 40-year-old claimed he did not have a contract with MLE or Nathan’s, and said the endorsement ban was a departure from the organization’s rules around partnerships in prior years.
“I love competing in that event, I love celebrating America with my fans all over this great country on the 4th and I have been training to defend my title,” he said last month.
While the relationship appears fried for the time being, the MLE called Chestnut an “American hero” and said it would “love” for him to return when not representing a Nathan’s competitor. Chestnut holds eating records in 55 categories, including eggs, chicken wings and apple pies, the MLE told NBC News.
Nathan’s website also still showers Chestnut in praise. In a section announcing his 2023 win, the New York-based company wrote that “there’s no doubt in our mind who’s the king.”
People wear hot dog outfits, as they attend the 2024 Nathan’s Famous Fourth of July International Hot Dog Eating Contest, at Coney Island, in New York City, U.S., July 4, 2024
Kent J. Edwards | Reuters
During ESPN’s broadcast of the 2024 contest, the channel made several mentions of Chestnut and what the competition looks like without him. In one reference, Chestnut was referred to as the “Warren Buffett of the buffet.”
Chestnut fans can still see him in action this holiday.
He’s livestreaming a hot dog eating contest from the Fort Bliss army base in Texas as a fundraiser for charity, according to a recent Instagram post. The show begins at 5 p.m. ET on Thursday.
“The 4th wouldn’t be the same if I wasn’t celebrating by eating a whole lot of all-beef hot dogs,” he wrote.